XML 37 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2016
Equity [Abstract]  
Summary of Outstanding Warrants Issued by Company

Below is a summary of outstanding warrants issued by the Company as of December 31, 2016:

 

Warrant Type

 

Number of Shares Issuable Upon Exercise

 

 

Weighted Average Exercise Price

 

 

Issue Date

 

Expiration Date

Consultant Warrant

 

 

85,000

 

 

$

10.70

 

 

August 13, 2014

 

August 13, 2019

Opus Warrant

 

 

200,000

 

 

 

2.19

 

 

March 31, 2014

 

March 31, 2019

New Opus Warrant #1

 

 

100,000

 

 

 

2.22

 

 

September 30, 2016

 

September 30, 2021

New Opus Warrant #2

 

 

100,000

 

 

 

3.61

 

 

December 31, 2016

 

December 31, 2021

2013 Private Placement Warrants

 

 

186,878

 

 

 

10.00

 

 

August 14, 2013

 

August 14, 2017

Total

 

 

671,878

 

 

 

 

 

 

 

 

 

 

Summary of Activity under Stock-Based Compensation Plans

A summary of activity for the Company’s stock option plans for the year ended December 31, 2016 follows:

 

 

Number

Outstanding

 

 

Average Exercise

Price per Share

 

 

Weighted Average

Remaining

Contractual Term

(Years)

 

 

Average Intrinsic

Value

 

Balance at December 31, 2015

 

781,804

 

 

$

11.48

 

 

 

 

 

 

$

 

Granted

 

444,460

 

 

 

4.36

 

 

 

 

 

 

 

 

 

Cancelled or Expired

 

(393,323

)

 

 

12.15

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2016

 

832,941

 

 

$

7.11

 

 

 

8.23

 

 

$

 

Vested or expected to vest at

   December 31, 2016

 

801,667

 

 

$

7.18

 

 

 

8.19

 

 

$

 

Exercisable at December 31, 2016

 

429,816

 

 

$

8.58

 

 

 

7.58

 

 

$

 

 

Summary Information about Options Outstanding

The following table summarizes information about options outstanding as of December 31, 2016:

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Range of Exercise Prices

 

Number Outstanding

 

 

Weighted Average Remaining Contractual Life (Years)

 

 

Weighted Average Exercise Price

 

 

Number Exercisable

 

 

Weighted Average Exercise Price

 

$4.36 - $7.20

 

 

530,810

 

 

 

9.00

 

 

$

4.55

 

 

 

207,619

 

 

$

4.78

 

$7.50 - $11.30

 

 

254,471

 

 

 

7.25

 

 

 

9.80

 

 

 

174,537

 

 

 

9.67

 

$12.00 - $19.70

 

 

27,390

 

 

 

6.29

 

 

 

13.66

 

 

 

27,390

 

 

 

13.66

 

$21.70 - $33.90

 

 

17,541

 

 

 

3.23

 

 

 

29.30

 

 

 

17,541

 

 

 

29.30

 

$34.40 - $43.40

 

 

2,729

 

 

 

0.22

 

 

 

43.40

 

 

 

2,729

 

 

 

43.40

 

$4.36 - $43.40

 

 

832,941

 

 

 

8.23

 

 

$

7.11

 

 

 

429,816

 

 

$

8.58

 

 

Weighted-average Assumptions Used in Estimating Fair Value of Option Grants by Using Black-Scholes Model

The fair value of option grants was estimated using the Black-Scholes model with the following weighted-average assumptions for the years ended December 31, 2016:

 

 

 

2016

 

 

2015

Risk-free interest rate

 

 

1.25%

 

 

N/A

Expected volatility

 

 

78.40%

 

 

N/A

Expected term in years

 

4.77

 

 

N/A

Dividend yield

 

 

0.00%

 

 

N/A

At December 31, 2016, there was $1.4 million of unrecognized stock-based compensation expense, net of estimated forfeitures related to unvested options, that is expected to be recognized over a weighted-average period of 2.1 years.  

 

Summary of Restricted Stock and Restricted Stock Unit (RSU) Activity

The following is a summary of restricted stock and restricted stock unit (“RSU”) activity for the year ended December 31, 2016:

 

 

Number Outstanding

 

 

Weighted Average Fair Value

 

Balance at December 31, 2015

 

721,918

 

 

$

13.32

 

Granted

 

2,252,732

 

 

 

2.19

 

Vested

 

(736,922

)

 

 

6.56

 

Forfeited

 

(264,269

)

 

 

14.64

 

Balance at December 31, 2016

 

1,973,459

 

 

$

2.80

 

 

Stock-Based Compensation Expense Related to Stock Options and RSUs

The following table illustrates all stock-based compensation expense related to stock options and RSUs included in the consolidated statements of operations for the years ended December 31, 2016 and 2015 (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2016

 

 

2015

 

Cost of revenue

 

$

76

 

 

$

85

 

Research and development

 

 

352

 

 

 

324

 

Selling and marketing

 

 

632

 

 

 

1,085

 

General and administrative

 

 

1,782

 

 

 

3,022

 

Total

 

$

2,842

 

 

$

4,516

 

 

Schedule of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance as of December 31, 2016 was as follows:

 

Exercise of outstanding stock options and vesting of RSUs

 

 

2,806,215

 

ESPP

 

 

293,888

 

Shares of common stock available for grant under the 2011 Plan

 

 

330,979

 

Noncontrolling interest in Bluehill AG

 

 

10,355

 

Warrants to purchase common stock

 

 

671,878

 

Total

 

 

4,113,315